MEI Pharma, Inc.
3611 Valley Centre Drive, Suite 500
San Diego, CA 92130
June 14, 2018
VIA EDGAR TRANSMISSION
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
| Attention: Abigail Jacobs |
Mary Beth Breslin
| Re: | MEI Pharma, Inc. |
Registration Statement on Form S-3
Filed June 6, 2018
File No. 333-225465
Ladies and Gentlemen:
Pursuant to Rule 461 under the Securities Act of 1933, as amended, MEI Pharma, Inc. (the “Company”), hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-225465), so that such registration statement may become effective at 4:00 p.m. (Washington, D.C. time) on June 18, 2018, or as soon as practicable thereafter.
| MEI PHARMA, INC. | ||||
| By: | /s/ Brian G. Drazba | |||
| Name: | Brian G. Drazba | |||
| Title: | Chief Financial Officer | |||